Post-test medical diagnostic accuracy measures: an innovative approach based on the area under F-scores curves

Clinicians have increasingly turned to F-scores to gauge the accuracy of diagnostic tests. However, the dependency of F-scores on the prevalence of the underlying illness poses challenges, especially when prevalence varies across regions or populations, potentially leading to misdiagnoses. To address this issue, this article presents novel post-test diagnostic precision metrics for continuous tests or biomarkers. These metrics are based on the collective areas under the F-score curves across all conceivable prevalence values. Unlike traditional measures, the proposed metrics remain constant regardless of disease prevalence, enabling fair comparisons of different diagnostic tests and biomarkers' abilities in rule-in, rule-out, and overall accuracy. The article also explores the relationship between the proposed metrics and other diagnostic accuracy measures. Numerical illustrations and a real-world breast cancer dataset exemplify the application of the proposed metrics.

Authors

Institutions

Publication Details

Journal
Journal of Biopharmaceutical Statistics
Published
2025-06-17
DOI
https://doi.org/10.1080/10543406.2025.2512989
Primary Topic
Machine Learning in Healthcare
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Post-test medical diagnostic accuracy measures: an innovative approach based on the area under F-scores curves

Marwan Alsharman, Jing Kersey, Hani Samawi
Journal of Biopharmaceutical Statistics
Machine Learning in Healthcare
article

Post-test medical diagnostic accuracy measures: an innovative approach based on the area under F-scores curves

Marwan Alsharman, Jing Kersey, Hani Samawi
article en

Abstract

Clinicians have increasingly turned to F-scores to gauge the accuracy of diagnostic tests. However, the dependency of F-scores on the prevalence of the underlying illness poses challenges, especially when prevalence varies across regions or populations, potentially leading to misdiagnoses. To address this issue, this article presents novel post-test diagnostic precision metrics for continuous tests or biomarkers. These metrics are based on the collective areas under the F-score curves across all conceivable prevalence values. Unlike traditional measures, the proposed metrics remain constant regardless of disease prevalence, enabling fair comparisons of different diagnostic tests and biomarkers' abilities in rule-in, rule-out, and overall accuracy. The article also explores the relationship between the proposed metrics and other diagnostic accuracy measures. Numerical illustrations and a real-world breast cancer dataset exemplify the application of the proposed metrics.

Journal of Biopharmaceutical Statistics
Georgia Southern University (US)
Openalex Percentile: Top 93%
Machine Learning in Healthcare
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.